concludes successfully
Global Thought Leaders
-
Dr. Seth Berkley
Chief Executive Officer,
GAVI Alliance,
Geneva. -
Mr. Kevin Ali
President, Emerging Markets,
Merck & Co. Inc.,
NJ, USA -
Dr. Richard D. Connell
Head (Asia-R&D)
Pfizer
Shangai, China. -
Prof. Nirmal Kumar Ganguly
Former Director General,
ICMR, New Delhi, India. -
Dr. Suresh Jadhav
Executive Director,
Serum Institute of India Ltd.
Pune, India. -
Dr. Hasit Joshipura
VP(South Asia) & MD (India)
GSK Pharmaceuticals Ltd.
Mumbai, India. -
Dr. Urmish Chudgar
Managing Director
Intas Biopharmaceuticals Ltd.
Ahmedabad, India. -
Dr. Anand Tharmaratnam
SVP and Head of Asia Markets,
Quintiles,
Singapore -
Dr. Harry S. Rathore
Managing Director and Head,
Lonza India Operations,
Hyderabad, India. -
Dr.Cyrus Karkaria
President, Biotechnology,
Lupin Pharma,
Pune, India. -
Dr. Darren Ji
CEO and Founder,
PharmaLegacy Laboratories,
Shanghai, China. -
Dr. P. V. Appaji
Executive Director
PHARMEXCIL,
Hyderabad, India. -
Mr. K V Balasubramaniam
Managing Director
Indian Immunologicals Ltd
Hyderabad, India. -
Mr. Swapan Bhattacharya
Managing Director,
TCG Lifesciences Limited -
Dr. Wenyong Wang
Managing Director,
Merchant & Investment Banking,
Burrill & Company
-
Dr Sumit Ghoshal
Deputy Editor,
Business India magazine -
Narayanan Suresh
Group Editor( Senior VP),
BioSpectrum -
Harish Iyer
CEO,
Shantha Biotechnics 
Dr. Ch. Mohan Rao
Director,
Centre for Cellular and Molecular Biology
Mr. Rajesh Rai
CEO,
India Innovation Fund
Dr. Shirshendu Mukherjee
Strategic Advisor,
R&D Initiative - India Wellcome Trust
Dr. Prabuddha K Kundu
Executive Director,
Premas Biotech
Dr. Sunny Sharma
Senior Managing Director,
Asia team of OrbiMed Advisors
Mr. Vishal Gandhi
SVP & Head – Lifesciences,
Yes Bank
Dr. Goutam Das
Chairman,
Goutam Das Consultancy,
India
Mr. Sai D. Prasad
Vice President - Business Development,
Bharat Biotech International Ltd.,
Hyderabad
Mr. Atul Aslekar
Co-Founder,
V-Lifesciences & Technology Pvt. Ltd.
Mr. Andy Rayner
Group Technology Director – PM Group
Mr. Kewal Handa
Managing Director - Pfizer Limited,
India
Mr. Utkarsh Palnitkar
Managing Director – Pluripotent Capital
Executive Director – Centrum Capital Ltd.
Mr. Venkat Jasti
CEO & Chairman,
Suven Life Sciences Ltd.
Dr. Nata Menabde
WHO Representative to India
Dr. Shreemanta K Parida
CEO, Vaccine Grand Challenge ProgramDept of Biotechnology,
Ministry of Science & Technology, Govt of India
Dr. Sanuj Ravindran
Managing Director, Asian Healthcare fund
Events and Promotions
About Us
Optimize your opportunities. Build global relationships.
Under the over arching theme of "Optimizing Opportunities", BioAsia 2012 will unfold as the widest and the most dynamic global forum on Life Sciences and Biotechnology. On one hand, it will bring together the captains of biotech & pharmaceutical companies, venture capitals, policy makers, industry analysts, academicians, universities, R&D hubs and other major stakeholders to translate the immense promise of the industry into potential outcomes. On the other, it will enable you to connect with the key stakeholders across categories to leverage your business interests. You will also witness the process that will drive the growth of this industry through innovations and evolutionary ideas.
From BioAsia 2012 you can clearly expect
- A vibrant global platform for key industry stakeholders - biotech & bio-pharma companies, research institutions, investors, service providers, policy makers, regulators and analysts.
- Knowledge and experience sharing support amongst academia and research scientists.
- Creation of a dynamic experience-pool to draw live instances from industry thought-leaders.
All this will be unleashed through designed focus on Vaccines, Investments, Contract Research and IP Rights.
This website can be best viewed in 1152 x 864 screen resolution.
